4.UNCAN.eu
HORIZON-CSA
2.989.634.00€
September 2022 – November 2023 (15 months)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
VIEW PARTNERS >Alleanza Contro Il Cancro, Italy
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia, Slovakia
Centre International De Recherche Sur Le Cancer, France
Childhood Cancer International, Netherlands
Consorcio Centro de Investigacion Biomedica En Red M.P., Spain
Deutsches Krebsforschungszentrum Heidelberg, Germany
European Cancer Patient Coalition, Belgium
Fundacio Privada Institut D’investigacio Oncologica De Vallhebron (VHIO), Spain
Helsingin Yliopisto, Finland
Inserm Transfert Sa, France
Institut National de la Sante et de La Recherche Medicale, France
Institut National Du Cancer Gip, France
Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe, Portugal
Kemijski Institut, Slovenia
Luxembourg Institute Of Health, Luxembourg
Masarykuv Onkologicky Ustav, Czech Republic
Medizinische Universitaet Wien, Austria
Ministry For Health – Government Of Malta, Malta
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie – Panstwowy Instytut Badawczy, Poland
Organisation Of European Cancer Institutes, Belgium
Orszagos Onkologiai Intezet, Hungary
Region Nordjylland (North Denmark Region), Denmark
SCIENSANO, Belgium
SIOP Europe, Belgium
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Netherlands
Stichting Oncode Institute, Netherlands
Tartu Ulikool, Estonia
Universite Paris-Saclay, France
University College Dublin, National University Of Ireland, Dublin, Ireland
Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos, Lithuania
Why it matters
The 15-month coordination and support action “4.UNCAN.eu” will generate a strategic agenda to launch UNCAN.eu, a European initiative to understand cancer proposed by the Mission Board and the European Beating Cancer Plan. This research agenda will be built with the final aim of achieving a new breakthrough in cancer prevention and treatment that will contribute to saving European citizens’ lives and help ensure an optimal quality of life to disease survivors.
What ECPC does
The general objectives of the project are to ensure that cancer patients and their relative have a central role and strong voice within the project activities while informing “4.UNCAN.eu” on European citizens’ expectations.
ECPC is involved in Work Package 4 that includes the role of European patients and citizens in cancer research. This Work Package comprises the following tasks and deliverables:
- Task 4.1: Empowering cancer patients and EU citizens
D4.1 Empowering patients & citizens plan – ECPC, report PU – Public, Month 3
- Task 4.2: Dissemination and communication strategy
D4.2 Empowering patients & citizens plan – ECPC, report PU – Public, Month 3
- Task 4.3: Dissemination and communication activities
The specific objectives of this Work Package are:
- To ensure that other WP leaders will properly consider patients’ unmet needs and priorities,
- To coordinate communication within “4.UNCAN.eu” and between the consortium and external stakeholders,
- To communicate and disseminate “4.UNCAN.eu” proposals and final outcome to the target audiences and key stakeholders (cancer patients and their relatives, care-givers, European citizens, cancer representatives and charities, healthcare professionals and academia, employers and policymakers),
- To define the role of patients in UNCAN.eu initiative and prepare the dissemination of cancer research results among younger European citizens in order to improve cancer prevention.

This project has received funding from the European Union’s Horizon Europe Coordination and Support Actions programme under grant agreement No 101069496